Dr. Rachel Farley-Loftus, MD

Dr. Farley-Loftus practices at Emmaus Surgical Center in Hackettstown, New Jersey.

Dr. Farley-Loftus' NPI, 1285845941, was assigned on May 24, 2007. Dr. Farley-Loftus graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Farley-Loftus' New Jersey license number on file is 25MA09201200.

Dr. Farley-Loftus' primary practice is Emmaus Surgical Center, at 57 Route 46, Suite 104, Hackettstown, NJ 07840. The practice phone is (908) 813-9600.

Dr. Farley-Loftus' primary practice is Emmaus Surgical Center in Hackettstown, New Jersey. The medical group on file is The Medical Group of New Jersey, Hackettstown Radiology. Dmand AI also links Dr. Farley-Loftus to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farley-Loftus practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Farley-Loftus' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Farley-Loftus is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Farley-Loftus' licenses on file in 3 states: New Jersey, North Carolina and New York.

Dmand AI lists benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, psoriasis, scalp rash, skin cyst and skin discoloration among the conditions Dr. Farley-Loftus treats.

CMS data shows 1,308 Medicare services from Dr. Farley-Loftus across 15 procedure codes in 2024, for 245 Medicare patients. Medicare paid $71,517 for them. Every service was in an office.

CMS counts 245 Medicare patients who saw Dr. Farley-Loftus in 2024. The largest group is 65 to 74, with 134 patients. 75% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 0.70, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farley-Loftus' median patient age at 54, with 66% women.

In 2024, Dr. Farley-Loftus wrote 220 Medicare Part D claims for 106 patients. 90% of them were for generic drugs. CMS names the drug for 105 of them, across 7 drugs with 11 or more claims each, at $2,153 in total drug cost. In 2023, CMS named 169 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Farley-Loftus for performance year 2024, reported as part of a group. Dr. Farley-Loftus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 250 procedures of skin biopsy by Dr. Farley-Loftus, more than 88% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Farley-Loftus in 2010. 2010 was the busiest year, with 2. Dr. Farley-Loftus has published most often in Dermatol Online J. Dr. Farley-Loftus' most frequent co-authors are Jesse Miller Lewin, MD, Miriam Pomeranz, MD and Sarina Berger Elmariah, MD, PhD.

CMS Open Payments shows 399 general payments to Dr. Farley-Loftus from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $829.

Dmand AI lists 2 awards for Dr. Farley-Loftus, most recently CMS Stage 1 2012 in 2012.

Dr. Farley-Loftus graduated from Vagelos College of Physicians and Surgeons in 2006. Dr. Farley-Loftus is a member of AAD.

Dr. Farley-Loftus is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.